54 posts categorized in

Publications

  

AACP Awards Dr. Cintia Citterio the New Investigator Award

May 28, 2024 by | Pharmacy

Dr. Cintia Citterio has been honored as a recipient of the 2024 American Association of Colleges of Pharmacy (AACP) New Investigator Award (NIA) for her proposal “Molecular Pathogenesis of Thyroid Cystinosis and New Therapeutic Approaches.” The AACP NIA is a highly competitive achievement that offers $11,000 to exceptional early-career pharmacy faculty members, placing Dr. Citterio

On the CUSP: April 2024

May 6, 2024 by | Pharmacy

Publications Dr. Keykavous Parang collaborated to produce “Harnessing exosomes as a platform for drug delivery in breast cancer: A Systematic review for in vivo and in vitro studies” in Molecular Therapy Oncology. Dr. Jelena Lewis and PharmD candidate Brenda Kilzi authored “Respiratory syncytial virus (RSV)—Who is at risk, and who can be vaccinated?” in Topics

BPS Paper of the Year Awarded to Dr. Sumbria

April 23, 2024 by | Research

The Department of Biomedical and Pharmaceutical Sciences (BPS) has awarded Dr. Rachita Sumbria  the 2023 BPS Paper of the Year Award. Dr. Sumbria recognition is based on her publication, “Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy.“ Dr. Sumbria’s groundbreaking research, conducted in collaboration with a

Dean Ostrom Provides Expertise for Verywell Health

April 19, 2024 by | Research

Dean Ren Ostrom recently provided his expertise in Verywell Health, a publication that reaches over 300 million readers annually. Dr. Ostrom discussed at length the implications of a recent study published in the New England Journal of Medicine regarding the necessity of beta-blockers for heart attack patients with preserved heart function. Dr. Ostrom emphasized the

NIH Awards Dr. Zhang $434K for Rare Genetic Disease Research

April 16, 2024 by | Research

Dr. Miao Zhang has been awarded a prestigious grant totaling $434,024 by the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH). This funding will support Dr. Zhang’s groundbreaking project “Channelopathy of KCa2.3 and Zimmermann-Laband syndrome,” aimed at unraveling the complexities surrounding Zimmermann-Laband syndrome 3 (ZLS3). Zimmermann-Laband syndrome 3

On the CUSP: March 2024

April 5, 2024 by | Research

Publications Dr. Ren Ostrom, Dr. Isabella Cattani-Cavalieri, Dr. Francisco Nuñez, Jordyn Margolis,  and PhD candidate Camelia Anicolaesei published Real-Time cAMP Dynamics in Live Cells Using the Fluorescent cAMP Difference Detector In Situ in JoVE Journal Dr. Rachita Sumbria, Dr. Nataraj Jagadeesan, Dr. Devaraj Chandrashekar, and Chuli Roules worked with others on “Modulation of hippocampal protein expression

Elyn Lam Awarded ASHP Student Leadership Award

April 5, 2024 by | Pharmacy

Elyn Lam has recently been awarded with the ASHP Student Leadership Award by the American Society of Health-System Pharmacists (ASHP). Set to graduate as a Doctor of Pharmacy in May, Elyn has been chosen as a recipient of this highly prestigious award from a pool of exceptionally qualified applicants from across the nation. She stood

CUSP Advances in Genetic Editing with CRISPR Technology

February 14, 2024 by | Research

Offering new prospects for medical inventions, Chapman University School of Pharmacy researchers continue to make strides in gene editing. The recent study “Modifying peptide/lipid-associated nucleic acids (PLANAs) for CRISPR/Cas9 ribonucleoprotein delivery” centers around the manipulation of genetic material through the CRISPR technology, a technology that has regained momentum since initial reports in 2005. The authors, including faculty

Chapman Finds Unexpected Outcome in Pandemic-Related Opioid Challenges

February 9, 2024 by | Research

Dialing in on years 2018-2021, Chapman University faculty have begun to bridge the data gap in understanding data trends on how buprenorphine was prescribed to both insured and uninsured patients in California. Contrary to past findings that relied on data to insured patients, the study “Real-World Dispensing of Buprenorphine in California during Prepandemic and Pandemic

Log In
Open Main Menu